Table: Kobayashi Pharmaceutical - 9-MTH group results

Kobayashi Pharmaceutical

11/11/2025 06:32

Nov 11 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            112.04              114.46           171.00    
                 (-2.1 pct)          (-3.9 pct)       (+3.3 pct)  
  Operating         11.50               16.98            14.00    
                 (-32.3 pct)         (-12.4 pct)      (-43.7 pct) 
  Recurring         12.93               17.92            15.30    
                 (-27.9 pct)         (-14.0 pct)      (-43.0 pct) 
  Net                6.81                5.34            10.50    
                 (+27.4 pct)         (-65.5 pct)      (+4.3 pct)  
  EPS             91.60 yen           71.90 yen       141.25 yen  
  Ann Div                            102.00 yen       104.00 yen  
  -Q2 div         44.00 yen           43.00 yen                   
  -Q4 div                             59.00 yen        60.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T